<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TableÂ 8. Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8% to 20% Higher</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td align="center" stylecode="     Toprule     ">
<content stylecode="bold">Study Population</content>
</td>
<td align="center" stylecode="     Toprule     ">
<content stylecode="bold">Regimens</content>
</td>
<td align="center" colspan="3">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule     "></td>
<td>
<paragraph>Divalproex Sodium Extended-release Tablets vs.</paragraph>Divalproex Sodium Delayed-release Tablets</td>
<td align="center" stylecode="     Botrule     ">AUC<sub>24</sub>
</td>
<td align="center" stylecode="     Botrule     ">C<sub>max</sub>
</td>
<td align="center" stylecode="     Botrule     ">C<sub>min</sub>
</td>
</tr>
<tr>
<td align="center">Healthy Volunteers<br/>(n = 35)</td>
<td align="center">
<paragraph>1000 mg &amp; 1500 mg<br/>Divalproex Sodium Extended-release Tablets vs.<br/>875 mg &amp; 1250 mg</paragraph>Divalproex Sodium Delayed-release Tablets</td>
<td align="center">1.059</td>
<td align="center">0.882</td>
<td align="center">1.173</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule     ">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs<br/>(n = 64)</td>
<td align="center" stylecode="     Botrule     ">
<paragraph>1000 mg to 5000 mg<br/>Divalproex Sodium Extended-release Tablets vs.<br/>875 mg to 4250 mg</paragraph>Divalproex Sodium Delayed-release Tablets</td>
<td align="center" stylecode="     Botrule     ">1.008</td>
<td align="center" stylecode="     Botrule     ">0.899</td>
<td align="center" stylecode="     Botrule     ">1.022</td>
</tr>
</tbody>
</table>